tradingkey.logo


Gelteq Ltd

GELS

1.640USD

+0.020+1.23%
āđ€āļ§āļĨāļēāļ—āļģāļāļēāļĢāļ•āļĨāļēāļ” ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
15.83MāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
āļ‚āļēāļ”āļ—āļļāļ™P/E TTM

āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Gelteq Ltd āļšāļĢāļīāļĐāļąāļ—
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
āļ‚āđ‰āļ­āļĄāļđāļĨāļšāļĢāļīāļĐāļąāļ—
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™GELS
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Gelteq Ltd
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 29, 2024
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Nathan Jacob Givoni
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™7
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Oct 29
āļ—āļĩāđˆāļ­āļĒāļđāđˆLevel 4
āđ€āļĄāļ·āļ­āļ‡MELBOURNE
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ Capital Market Consolidated
āļ›āļĢāļ°āđ€āļ—āļĻAustralia
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ3205
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ61390873990
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.gelteq.com
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™GELS
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 29, 2024
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Nathan Jacob Givoni
āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Nathan Jacob Givoni
Mr. Nathan Jacob Givoni
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
657.09K
--
Mr. Simon Hayden Szewach
Mr. Simon Hayden Szewach
Executive Chairman of the Board
Executive Chairman of the Board
338.20K
--
The Hon. Philip A. Dalidakis
The Hon. Philip A. Dalidakis
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Prof. David Morton
Prof. David Morton
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Jeffrey W. (Jeff) Olyniec
Mr. Jeffrey W. (Jeff) Olyniec
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Anthony W. Panther
Mr. Anthony W. Panther
Chief Financial Officer
Chief Financial Officer
--
--
āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 17 āļž.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 17 āļž.āļ„.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Markoff (Jeffrey)
25.86%
Golik (David)
10.73%
Givoni (Nathan Jacob)
6.96%
Crestmont Pty Ltd
6.81%
Barabash Family Trust
4.67%
Other
44.97%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Markoff (Jeffrey)
25.86%
Golik (David)
10.73%
Givoni (Nathan Jacob)
6.96%
Crestmont Pty Ltd
6.81%
Barabash Family Trust
4.67%
Other
44.97%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Individual Investor
48.88%
Corporation
11.48%
Research Firm
0.59%
Hedge Fund
0.27%
Investment Advisor
0.25%
Other
38.53%
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q2
15
5.80M
61.47%
+24.19K
2025Q1
15
5.80M
61.47%
+24.19K
2024Q4
13
5.78M
61.21%
+80.95K
āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™î™Œ
āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
Markoff (Jeffrey)
2.44M
25.86%
--
--
Nov 15, 2024
Golik (David)
1.01M
10.73%
--
--
Nov 15, 2024
Givoni (Nathan Jacob)
657.09K
6.96%
--
--
Nov 15, 2024
Crestmont Pty Ltd
642.32K
6.81%
--
--
Nov 15, 2024
Barabash Family Trust
441.00K
4.67%
--
--
Nov 15, 2024
Szewach (Simon Hayden)
338.20K
3.58%
--
--
Nov 15, 2024
Olyniec (Jeffrey W.)
164.81K
1.75%
--
--
Nov 15, 2024
Wedbush Securities, Inc.
52.25K
0.55%
+1.25K
+2.45%
Mar 31, 2025
UBS Financial Services, Inc.
23.45K
0.25%
+17.25K
+278.35%
Mar 31, 2025
Citadel Advisors LLC
15.16K
0.16%
-8.58K
-36.14%
Mar 31, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡î™Œ
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™î™Œ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™